Table 2 Comparisons of labor and delivery outcomes in three groups
From: Labor induction with randomized comparison of cervical, oral and intravaginal misoprostol
Variable | Cervical group | Sublingual group | Vaginal group | p-value |
|---|---|---|---|---|
Time to Active phase (hours) (M ± SD) | 3.01 ± 0.86 | 4.2 ± 0.66 | 5.06 ± 1.1 | < 0.001 |
Time to delivery (hours) (M ± SD) | 6.1 ± 1.3 | 8.4 ± 0.92 | 9.2 ± 1.5 | <  0.001 |
Single dose of misoprostol: n (%) | 96(96%) | 63(63%) | 28(28%) | 0.000 |
Mode of delivery: n (%) | ||||
 Vaginal delivery | 93(93) | 83(83) | 83(83) | 0.05 |
 Caesarean | 7(7.0) | 17(17.0) | 17(17.0) |  |
Gastrointestinal implication | 0 | 0 | 0 | – |
Hyperstimulation | 0 | 0 | 0 | – |
Tachysystol | 0 | 0 | 0 | – |
Failure to progress: n (%) | ||||
 Yes | 4(4%) | 5(5%) | 6(6%) | 0.81 |
 No | 94(94%) | 95(95%) | 96(96%) |  |